Read more about FDA Approves Olaparib for Frontline Maintenance Treatment in Ovarian Cancer
FDA Approves Olaparib for Frontline Maintenance Treatment in Ovarian Cancer
...to 70% in women with BRCA 1 or 2 positive, advanced stage epithelial ovarian, fallopian tube, and primary peritoneal cancers. Those included in the study received cytoreductive surgery and had...